Found 29 matching trials
A Repeated-Dose Evaluation of Use of a Pain Relieving Drug and Safety of OROS Hydromorphone HCI in Patients With Chronic Cancer Pain PHASE3 The purpose of this repeated dose study is to develop recommended dosing in...
Show More Location
Multiple Locations
Learn More & Join Trial
A Randomized, Open-Label, Single-Dose, Small Study to Evaluate the Safety and Effectiveness of Hydromorphone in Patients With Short Term, Moderate to Severe Postoperative Pain PHASE2 The purpose of this small study was to investigate the safety and effective...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Tolerability of Long-term Administration of OROS Hydromorphone HCI (Slow Release) in Cancer Pain PHASE3 The primary purpose of this study was to characterize the pain control achi...
Show More Location
Multiple Locations
Learn More & Join Trial
An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release) PHASE3 The purpose of this study was to characterize the effectiveness and safety ...
Show More Location
Multiple Locations
Learn More & Join Trial
An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain PHASE3 The purpose of this study is to compare the safety and efficacy of Oral Osm...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Evaluate the Effectiveness and Safety of Slow Release Hydromorphone HCL for Treatment of Patients With Osteoarthritis PHASE3 The purpose of this study was to compare the analgesic (a drug that relieve...
Show More Location
Multiple Locations
Learn More & Join Trial
Placebo-controlled Trial With OROS Hydromorphone Hydrochloride to Treat Patients With Moderate to Severe Pain Induced by Osteoarthritis of the Hip or the Knee PHASE3 This clinical trial tests the pain relieving effectiveness of OROS hydromor...
Show More Location
Multiple Locations
Learn More & Join Trial
A Repeated-Dose Evaluation of a Pain Relieving Drug Use and Safety of OROS Hydromorphone HCI in Patients With Chronic Non-Malignant Pain PHASE3 The purpose of this repeated dose study is to develop recommended dosing in...
Show More Location
Multiple Locations
Learn More & Join Trial
An Observational Study to Investigate Clinical Usefulness of OROS Hydromorphone in Korean Cancer Patients N/A This study aims to collect clinical information and to examine the usefulne...
Show More Location
Multiple Locations
Learn More & Join Trial
A Repeated Dose Study of the Metabolism and Action Evaluation of OROS Hydromorphone HCI (Slow Release) Tablets in Patients With Chronic Pain PHASE1 The purpose of this study was to characterize the steady-state pharmacokine...
Show More Location
Multiple Locations
Learn More & Join Trial